Qiu Tian, Li Weihua, Geng Huilin, Shi Susheng
Department of Pathology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing, China.
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10941-10946. eCollection 2017.
Primary pancreatic lymphoma (PPL), originating from the pancreatic parenchyma, is a rare type of lymphoma. The symptoms and radiographic findings of PPL are quite similar to pancreatic adenocarcinoma (PAC), and thus it is often misdiagnosed. In this study, we described the clinical features, radiographic findings, histological and immunohistochemical analysis, molecular detection and clinical treatment of two cases of PPL, aiming to distinguish PPL from PAC. The two cases were both low-grade PPL. One was follicular lymphoma and the other was small lymphocytic lymphoma. Imaging examination of the two cases both showed solid mass, thus highly suspecting of PAC. However, after surgery, PPL was diagnosed by the pathologists through histopathological observation, immunohistochemistry (IHC) assay and clonality analysis. Therefore, accurately diagnosing and classifying of PPL is essential for patient management, since PPL is a treatable malignant tumor.
原发性胰腺淋巴瘤(PPL)起源于胰腺实质,是一种罕见的淋巴瘤类型。PPL的症状和影像学表现与胰腺腺癌(PAC)非常相似,因此常被误诊。在本研究中,我们描述了2例PPL的临床特征、影像学表现、组织学和免疫组化分析、分子检测及临床治疗情况,旨在将PPL与PAC区分开来。这2例均为低级别PPL。1例为滤泡性淋巴瘤,另1例为小淋巴细胞淋巴瘤。2例的影像学检查均显示为实性肿块,因此高度怀疑为PAC。然而,术后病理学家通过组织病理学观察、免疫组化(IHC)检测和克隆性分析诊断为PPL。因此,准确诊断和分类PPL对患者的治疗管理至关重要,因为PPL是一种可治疗的恶性肿瘤。